MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Safinamide effect in patients with Parkinson’s disease and deep brain stimulation

    F. Mancini, A. Di Fonzo, G. Lazzeri, L. Borellini, V. Silano, M. Lacerenza, C. Comi (Milan, Italy)

    Objective: Aim of this retrospective study is to evaluate safety and efficacy of safinamide in the treatment of motor complications in patients with Parkinson’s Disease…
  • 2018 International Congress

    After Deep Brain Stimulation Surgery for Parkinson’s Disease risk Factors for Postoperative Delirium

    F. Rakhimov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: The aim of this study was to investigate the incidence of and risk factors for postoperative delirium (POD) after deep brain stimulation (DBS) surgery…
  • 2018 International Congress

    On Converting Patients From Oral Dopamine Agonists to the Carbidopa/Levodopa Enteral Suspension Method – Real World Conversion Ratios

    S. Nakano, L. Bahroo, F. Pagan, F. Amjad, S. Lo, I. Gambhir (Washington, D.C., DC, USA)

    Objective: To review guidelines for initiating Carbidopa/Levodopa Enteral Suspension method of delivery in the treatment of Parkinson’s Disease (PD) and to compare guidelines with real…
  • 2018 International Congress

    Clinical trial protocol: Restitution of oral transport, penetration and aspiration with nigral stimulation in Parkinson’s disease?

    A. Schoellmann, L. Stoll, B. Hobl, C. Meisner, A. Gharabaghi, D. (Tuebingen, Germany)

    Objective: In this randomized controlled clinical trial, we aim to characterize the differential effect of subthalamic nucleus (STN) or subthalamic nucleus and substantia nigra pars…
  • 2018 International Congress

    A phase Ib trial studying the safety and tolerability of IRL790 in patients with Parkinson’s disease and levodopa-induced dyskinesia

    P. Svenningsson, A. Johansson, D. Nyholm, P. Tsitsi, C. Sonesson, J. Tedroff (Stockholm, Sweden)

    Objective: The primary objective was to investigate the safety and tolerability of IRL790 in PD patients with LID in a randomized controlled trial. Background: IRL790…
  • 2018 International Congress

    Quantifying the Reproducibility of an In Vivo Assay: Examination of Historical Amantadine Effects in the macaque Model of L-DOPA-Induced Dyskinesia

    E. Pioli, P. Stanley, W. Ko, Q. Li, R. Kozak, P. Popiolek, E. Bezard (Manchester, United Kingdom)

    Objective: This study was designed to assess the reproducibility of the amantadine anti-dyskinetic effect in the MPTP L-DOPA-Induced Dyskinesia (LID) macaque model for soundly defining…
  • 2018 International Congress

    Can blood biomarkers differentiate Idiopathic Parkinson’s disease from Parkinson plus syndromes? A study from North Indian population

    R. Shree, M. Mulagala, M. Modi, S. Mehta, M. Goyal, B. Medhi, V. Lal, B. Mittal (Chandigarh, India)

    Objective: To study the role of serum DJ-1 and Apo A1 in the differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes (PPS) in…
  • 2018 International Congress

    PROtein, LEucine And vitamin D Enhancing Rehabilitation (PRO-LEADER) in patients with Parkinson’s disease or parkinsonism: A RCT

    M. Barichella, E. Cereda, G. Pinelli, L. Iorio, D. Caroli, I. Masiero, V. Ferri, E. Cassani, C. Bolliri, S. Caronni, P. Ortelli, D. Ferrazzoli, A. Maras, G. Riboldazzi, G. Frazzitta, G. Pezzoli (Milano, Italy)

    Objective: We evaluated the efficacy of a muscle-targeted nutritional support on the outcomes of a multidisciplinary intensive rehabilitation treatment (MIRT). Background: Physical rehabilitation is an…
  • 2018 International Congress

    Eye Movement Abnormalities Correspond to Pontine Atrophy in Wilson Disease

    J. Hanuška, P. Dušek, J. Rusz, O. Ulmanová, A. Burgetová, E. Růžička (Prague, Czech Republic)

    Objective: This study aims to characterize eye movement (EM) abnormalities in Wilson´s disease (WD) and to assess their relation to clinical severity of WD and…
  • 2018 International Congress

    Transient dystonia of infancy: 25 cases

    V. Naranjo, M. Troncoso, A. Barrios, L. Troncoso, S. Witting, S. Lara, D. Muñoz, M. Hidalgo, I. Ruiz (Santiago, Chile)

    Objective: Characterize a group of pediatric patients with transient dystonia of infancy. Background: Transient dystonia of infancy is a Developmental and Benign Movement Disorder characterized…
  • « Previous Page
  • 1
  • …
  • 160
  • 161
  • 162
  • 163
  • 164
  • …
  • 177
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley